CodaVax
- Generic Name
- CodaVax
Intramuscular CodaVax-H1N1 in Healthy Adults
Phase 1
Completed
- Conditions
- Influenza, Human
- Interventions
- First Posted Date
- 2022-02-03
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- Codagenix, Inc
- Target Recruit Count
- 69
- Registration Number
- NCT05223179
- Locations
- 🇦🇺
Lis Gilmour, Senior Project Manager, Morayfield, Queensland, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath